Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
HTL-Strefa S.A.
With
Medical University of Lodz
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients with diagnosed diabetes type 1 or 2 ,
aged 18 - 50,
period of suffering from diabetes \>2 years,
performing on average 3-8 daily measurements of glycaemia,
glycaemia at the moment of the beginning of the study between 70 and 200 mg/dl.
You may not be if
glycaemia below 70 mg/dl or glycaemia above 200 mg/dl at the moment of the beginning of the study,
previously diagnosed hemorrhagic diathesis or heavy bleedings in the past (also those without a medical diagnosis),
anticoagulant (thrombolytic medication) therapy within 3 weeks prior to the study or on the day of the study,
non steroidal anti-inflammatory drugs (NSAID) treatment 1 week prior to the study or on the day of the study,
patients with signs of dehydration,
patients who are currently participating in another clinical study,
currently diagnosed or reported by the patient skin diseases, nervous system diseases, psychiatric diseases, etc., which, in the opinion of the person conducting the study, disqualify the patient from the participation in the study, in care for the patient's well-being.
Clareo Health | Comparison of Three Lancing Devices Regarding Capillary Blood Volume and Lancing Pain Intensity.
